News

  • Innovation must be part of the cost evaluation of healthcare

    March 11, 2014
    Arguments can be made on both sides about access and quality, when comparing our healthcare system to the rest of the industrialized world. But, few would dispute that American healthcare is the most innovative in the world. In fact, the creativity and expertise of American manufacturers, doctors, hospitals and Academic Medical Centers, laboratories, drug companies, health IT companies, and other participants set the standardContinue Reading »...
  • ACLA on President’s FY 2015 Budget

    March 04, 2014
    (Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today pointed to both beneficial and harmful provisions in the President’s FY 2015 budget: drastic funding cuts that would compromise the continued delivery of high quality clinical lab services to Medicare beneficiaries and a proposal that would preserve integrity in the lab services industry. ACLA urged congressional budget leaders to oppose provisions that would reduceContinue Reading »...
  • Congressional Letter to Secretary Hagel about TRICARE

    February 27, 2014
    ...
  • ACLA: TRICARE Decision to Deny Coverage of Molecular Diagnostic Tests Compromises Standard of Care for Military Families

    February 26, 2014
    (Washington, D.C.) – In a statement to the House Armed Services Subcommittee on Military Personnel addressing a hearing on the Defense Health Agency (DHA), the American Clinical Laboratory Association (ACLA) today expressed strong opposition to TRICARE’s current policy of non-coverage for molecular diagnostic tests provided to TRICARE beneficiaries seeking care through the community provider network. “There is no sound clinical or regulatory rationale forContinue Reading »...
  • ACLA Statement for House Military Personnel Subcommittee Hearing on Defense Health Agency

    February 26, 2014
    The American Clinical Laboratory Association (ACLA) thanks the Members of the House Military Personnel Subcommittee for consideration of our comments for the hearing, “Defense Health Agency.”  ACLA is a not-for-profit association representing the nation’s leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies.   Clinical laboratories provide critical testing services to TRICAREContinue Reading »...
  • Lab testing a Medicare cost saver

    February 18, 2014
    Sen. Ron Wyden (D-Ore.), the new chairman of the Senate Finance Committee and a longtime champion of improving chronic disease care, is in a position to play an important role in reforming Medicare. Wyden has long advocated a Medicare program that would feature improved care coordination for chronic disease, which would save lives and improve the quality of life for beneficiaries, while saving MedicareContinue Reading »...
  • Representative Sample of Tests No Longer Covered by TRICARE

    February 10, 2014
      Note: this is not a comprehensive list. For additional reading on this issue, please see the following articles: “DHA operations chief vows some relief from surprise lab fees,” Stars and Stripes, Feb. 6, 2014 “Some lab fees soon will be billed to Tricare patients,” Stars and Stripes, Jan. 9, 2014 Download PDF...
  • DHA operations chief vows some relief from surprise lab fees

    February 06, 2014
    Army Maj. Gen. Richard W. Thomas, newly assigned as chief medical officer and director of healthcare operations for the new Defense Health Agency (DHA), acknowledges that some Tricare patients and their civilian physicians face lab fee challenges that the DHA needs to address. A year ago Tricare, the military’s health insurance program, quietly stopped reimbursing civilian laboratories for more than 100 genetic or laboratory-developedContinue Reading »...
  • Pay cuts could wipe out labs, hurt nursing homes

    February 05, 2014
    When it comes to worries about how Medicare doctors will be paid, nursing home operators have thought they should stand at the front of a long and anxious line. Truth be told, they have some stiff competition for the “most nervous” title. That might go to the clinical lab folks. Although many provider groups are worried about which will have to sacrifice the mostContinue Reading »...
  • A Statement from the American Clinical Laboratory Association (ACLA) on the HHS-CMS Final Rule Allowing Patients Direct Access to Personal Laboratory Results

    February 04, 2014
    On behalf of ACLA — a not-for-profit association representing the nation’s leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies – ACLA President Alan Mertz issued the following statement: The ACLA today expressed its support for a new regulation issued by the Department of Health and Human Services (HHS), to be released inContinue Reading »...